SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-418634
Filing Date
2014-11-19
Accepted
2014-11-19 17:07:19
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d801363d10q.htm 10-Q 306311
2 EX-31.1 d801363dex311.htm EX-31.1 7224
3 EX-31.2 d801363dex312.htm EX-31.2 7302
4 EX-32 d801363dex32.htm EX-32 4596
  Complete submission text file 0001193125-14-418634.txt   3348262

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crxm-20140930.xml EX-101.INS 379191
6 XBRL TAXONOMY EXTENSION SCHEMA crxm-20140930.xsd EX-101.SCH 41130
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crxm-20140930_cal.xml EX-101.CAL 44088
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crxm-20140930_def.xml EX-101.DEF 119012
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crxm-20140930_lab.xml EX-101.LAB 337025
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crxm-20140930_pre.xml EX-101.PRE 219933
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Taxus Cardium Pharmaceuticals Group Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 141236524
SIC: 2836 Biological Products, (No Diagnostic Substances)